ACGL Arch Capital (ACGL) Insider Trading, Ownership & Congress Trades
Insurance · Fire, marine & casualty insurance · CIK 0000947484
Form 144 · 1
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
431
13F, latest reported quarter
Conversions, 180 days
1
Codes C/M, not in net · $298.2K priced
What the filings say about ACGL
Insiders, 180 days
-$688.1K net sold
1 buyer · 2 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-05-12
Planned sales (Form 144), 90 days
$1.1M
1 notice
Arch Capital insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, ARCH CAPITAL GROUP LTD. insiders sold a net $688.1K of stock across 61 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 10 earlier Form 4 trades (code P or S) here by this insider (10 sales), the last on Nov 28, 2025.
- The trade is 6.0% of the 184,826 shares held after it.
- No other insider sold within 30 days.
- 431 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CFO and Treasurer Morin Francois sold about $1.1M of ACGL on Aug 18, 2026; 431 funds added in the latest 13F quarter.Context
- 5 earlier Form 4 trades (code P or S) here by this insider (3 buys, 2 sales), the last on May 11, 2026.
- -1.5% median (+2.5% mean) 90-day return after 3 previous buys.
- No other insider sold within 30 days.
- 431 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Posner Brian S sold about $59.0K of ACGL on Jun 3, 2026; 431 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (3 buys, 1 sale), the last on Mar 11, 2026.
- -1.5% median (+2.5% mean) 90-day return after 3 previous buys.
- No other insider sold within 30 days.
- 431 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Posner Brian S sold about $34.3K of ACGL on May 11, 2026; 431 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 53.5% of the 9,915 shares held after it.
- No other insider bought within 30 days.
- 431 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Houston Daniel Joseph bought about $498.7K of ACGL on Apr 30, 2026, the largest insider purchase at the company since 2021; 431 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Aug 1, 2025.
- -1.5% median (+2.5% mean) 90-day return after 3 previous buys.
- The trade is 150.0% of the 2,000 shares held after it.
- 3 other insiders sold within 30 days.
- 431 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Posner Brian S sold about $51.4K of ACGL on Mar 11, 2026; 3 other insiders sold within 30 days and 431 funds added in the latest 13F quarter.61 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$688.1K over 180 days
-$1.1M over 90 days
more than 66% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
431 funds bought in last quarter
more than 81% of Insurance
Revenue
+14.3% year over year
more than 62% of Insurance
Margin
22.1% net margin
more than 76% of Insurance
Buybacks
$1.9B repurchased, FY to 2026-06-30
more than 95% of Insurance
Short interest
2.4% of the float short (float per yahoo 2026-10-26) · 1.6 days to cover · settled 2026-09-30
below 64% of Insurance
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch ACGL
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+16.5%12M
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns ACGL: institutional holders (13F)
13F holdings, latest reported quarter
30,220,703 sh
$2.9B
22,221,428 sh
$2.2B
21,595,895 sh
$2.1B
16,251,212 sh
$1.6B
15,872,450 sh
$1.5B
Congress trades in ACGL
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2025-05-12 · disclosed 41 days later
$15,001 - $50,000
Sold 2025-02-25 · disclosed 30 days later
$1,001 - $15,000
Bought 2025-02-24 · disclosed 13 days later
$15,001 - $50,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
ACGL planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Morin Francois
Filed 2026-08-18
$1.1M
Gansberg David
Filed 2026-07-20
$7.6M
Gansberg David
Filed 2026-07-02
$8.0M
Gansberg David
Filed 2026-06-26
$3.2M
ACGL mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
ICON CONSUMER SELECT
$1.5M position · as of 2026-06-30
5.7%
MARSHFIELD CONCENTRATED OPPORTUNITY FUND
$62.6M position · as of 2026-05-31
5.0%
Invesco KBW Property & Casualty Insurance ETF
$9.4M position · as of 2026-05-31
3.9%
iShares U.S. Insurance ETF
$15.9M position · as of 2026-06-30
3.8%
THRIVENT MID CAP STOCK FUND
$80.2M position · as of 2026-07-31
2.6%
THRIVENT MID CAP STOCK PORTFOLIO
$47.3M position · as of 2026-06-30
2.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Marc Grandisson
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$13.1M
$21.6M
$5.6M
+106%
+57%
2022
$12.1M
$20.6M
$4.7M
+74%
+42%
2021
$9.3M
$16.3M
$5.6M
+23%
+19%
2020
$8.8M
$2.8M
$3.9M
-16%
+7%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $688.1K sold by insiders over 180 days, 431 funds added last quarter, $1.1M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
ACGL financials
Revenue growth
+14.3%
XBRL, annual
Net margin
22.1%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$19.2B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM ACGL
| FY Dec 2025 | $19.9B |
| FY Dec 2024 | $17.4B |
| FY Dec 2023 | $13.6B |
| FY Dec 2022 | $9.6B |
| FY Dec 2021 | $9.2B |
| Jun 2026 | $4.7B |
| Mar 2026 | $4.5B |
| Dec 2025 | $4.9B |
| Sep 2025 | $5.1B |
| Jun 2025 | $5.2B |
| Mar 2025 | $4.7B |
| Dec 2024 | $4.5B |
| Sep 2024 | $4.7B |
At each fiscal year end
Single quarter
Net margin, TTM
+24.4%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM ACGL
| FY Dec 2025 | +22.1% |
| FY Dec 2024 | +24.7% |
| FY Dec 2023 | +32.6% |
| FY Dec 2022 | +15.4% |
| FY Dec 2021 | +23.3% |
| Jun 2026 | +22.6% |
| Mar 2026 | +23.2% |
| Dec 2025 | +25.1% |
| Sep 2025 | +26.4% |
| Jun 2025 | +23.7% |
| Mar 2025 | +12.3% |
| Dec 2024 | +20.6% |
| Sep 2024 | +20.9% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$6.1B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM ACGL
| FY Dec 2025 | $6.1B |
| FY Dec 2024 | $6.6B |
| FY Dec 2023 | $5.7B |
| FY Dec 2022 | $3.8B |
| FY Dec 2021 | $3.4B |
| Jun 2026 | $1.3B |
| Mar 2026 | $1.2B |
| Dec 2025 | $1.4B |
| Sep 2025 | $2.2B |
| Jun 2025 | $1.1B |
| Mar 2025 | $1.4B |
| Dec 2024 | $1.6B |
| Sep 2024 | $2.0B |
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity ACGL
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt ACGL
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+19.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity ACGL
| FY Dec 2025 | +19.5% |
| FY Dec 2024 | +22.0% |
| FY Dec 2023 | +28.4% |
| FY Dec 2022 | +11.2% |
| FY Dec 2021 | +16.2% |
| Jun 2026 | +19.9% |
| Mar 2026 | +21.3% |
| Dec 2025 | +19.5% |
| Sep 2025 | +17.8% |
| Jun 2025 | +17.1% |
| Mar 2025 | +18.4% |
| Dec 2024 | +22.0% |
| Sep 2024 | +30.4% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+5.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets ACGL
| FY Dec 2025 | +5.9% |
| FY Dec 2024 | +6.6% |
| FY Dec 2023 | +8.3% |
| FY Dec 2022 | +3.2% |
| FY Dec 2021 | +4.9% |
| Jun 2026 | +5.7% |
| Mar 2026 | +6.2% |
| Dec 2025 | +5.9% |
| Sep 2025 | +5.4% |
| Jun 2025 | +5.2% |
| Mar 2025 | +5.5% |
| Dec 2024 | +6.6% |
| Sep 2024 | +8.9% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital ACGL
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed ACGL
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
8.01x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing ACGL
| FY Dec 2025 | 8.26x |
| FY Dec 2024 | 8.25x |
| FY Dec 2023 | 6.39x |
| FY Dec 2022 | 16.56x |
| FY Dec 2021 | 8.50x |
| Jun 2026 | 7.59x |
| Mar 2026 | 7.38x |
| Dec 2025 | 8.26x |
| Sep 2025 | 8.50x |
| Jun 2025 | 9.41x |
| Mar 2025 | 9.86x |
| Dec 2024 | 8.25x |
| Sep 2024 | 7.51x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value ACGL
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+17.3%
TTM free cash flow over market value at close 2026-10-26
FCF yield ACGL
| FY Dec 2025 | +17.6% |
| FY Dec 2024 | +19.1% |
| FY Dec 2023 | +20.6% |
| FY Dec 2022 | +16.2% |
| FY Dec 2021 | +19.7% |
| Jun 2026 | +17.9% |
| Mar 2026 | +17.2% |
| Dec 2025 | +17.6% |
| Sep 2025 | +18.6% |
| Jun 2025 | +18.0% |
| Mar 2025 | +18.1% |
| Dec 2024 | +19.1% |
| Sep 2024 | +16.0% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.25x
P/E over trailing EPS growth of 32%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing ACGL
| FY Dec 2025 | 2.20x |
| FY Dec 2024 | n/a |
| FY Dec 2023 | 0.03x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 0.15x |
| Jun 2026 | 0.24x |
| Mar 2026 | 0.22x |
| Dec 2025 | 2.20x |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | 0.08x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $19.9B | $17.4B | $13.6B | $9.6B |
| Net income | $4.4B | $4.3B | $4.4B | $1.5B |
| EPS (diluted) | 11.60 | 11.19 | 11.62 | 3.80 |
| Operating cash flow | $6.2B | $6.7B | $5.7B | $3.8B |
| Cash | $993.0M | $979.0M | $917.0M | $855.0M |
| Buybacks | $1.9B | $24.0M | $0 | $586.0M |
SEC XBRL, fiscal years, as known on 2026-10-27
ACGL Stock Sonar score 5/7 axes
Find similar shapesCompareACGL ranks highest on institutional and government (81st percentile) and profitability (71st), and lowest on risk and compliance (53rd), among Insurance peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
ACGL filings, in plain words
Are Arch Capital insiders buying or selling ACGL?
In the 180 days to 2026-10-27, Arch Capital insiders were net sellers, a net $688.1K: $498.7K of purchases and $1.2M of sales reported on Form 4, by 1 buyer and 2 sellers.
Have members of Congress traded ACGL?
Yes, but not in the year to 2026-10-27; the latest on record is a sale by Jefferson Shreve dated 2025-05-12.
Are there planned insider sales of ACGL?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-27, covering $1.1M of stock; the latest, by Morin Francois, was filed 2026-08-18.
Read the full summary
In the 180 days to 2026-10-27, Arch Capital insiders were net sellers of ACGL, a net $688.1K across purchases and sales reported on Form 4 by 1 buyer and 2 sellers. None of the 3 insider sales was flagged as made under a Rule 10b5-1 plan. Members of Congress have disclosed trades in ACGL, none in the last year; the latest on record is a sale by Jefferson Shreve dated 2025-05-12. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-27, covering $1.1M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
